Quarterly report pursuant to Section 13 or 15(d)

Note 1 - The Company and Summary of Significant Accounting Policies (Details Narrative)

v3.20.2
Note 1 - The Company and Summary of Significant Accounting Policies (Details Narrative) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Dec. 31, 2019
Dec. 31, 2018
Accounting Policies [Abstract]            
Accumulated deficit $ (580,695)   $ (580,695)   $ (567,332)  
Cash and cash equivalent 350 $ 313 350 $ 313 $ 28 $ 60
Cash in excess of insured limit 100   $ 100      
Stock options granted     0 0    
Diluted shares excluded from calcuation of EPS     114,887,906 73,520,680    
Research and development $ (84) $ 671 $ 252 $ 1,659